Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $57.66 -5.43%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Wedbush analyst Martin Fan raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Defending Shopify (SHOP) Amid Heavy Selling Day: 'Muse Headlines Offer Buying Opportunity'
- Jayden Resources closes oversubscribed private placement at $1.03M
- Abacus founders cancel share-sale plans, keep ownership stakes
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
